- 股價
44.65
- 漲跌
▲0.25
- 漲幅
+0.56%
- 成交量
3張
- 產業
上市 生技醫療類股
-
本地時間:13:30
月營收報表
因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。
羅麗芬-KY (6666) 月營收報表
| 年度/月份 | 營業收入(單位:千元) | 累計營業收入(單位:千元) |
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 |
| 2025/10 | 67,109 | 70,009 | -35.3% | -4.1% | 920,789 | 957,904 | -3.9% |
| 2025/09 | 103,691 | 108,839 | 49.3% | -4.7% | 853,680 | 887,895 | -3.8% |
| 2025/08 | 69,461 | 101,133 | -17.4% | -31.3% | 749,910 | 779,056 | -3.7% |
| 2025/07 | 84,131 | 88,435 | -35% | -4.9% | 680,449 | 677,923 | 0.4% |
| 2025/06 | 129,546 | 130,812 | 11.1% | -1% | 596,318 | 589,488 | 1.1% |
| 2025/05 | 116,644 | 111,649 | 14.4% | 4.5% | 466,772 | 458,676 | 1.8% |
| 2025/04 | 101,981 | 108,404 | -14.6% | -5.9% | 350,128 | 347,027 | 0.9% |
| 2025/03 | 119,469 | 108,435 | 79% | 10.2% | 248,147 | 238,623 | 4% |
| 2025/02 | 66,741 | 73,701 | 7.8% | -9.4% | 128,678 | 130,188 | -1.1% |
| 2025/01 | 61,937 | 56,487 | -40.5% | 9.6% | 61,937 | 56,487 | 9.6% |
| 2024/12 | 104,073 | 104,282 | 61.2% | -0.2% | 1,126,524 | 971,050 | 16% |
| 2024/11 | 64,547 | 84,312 | -7.8% | -23.4% | 1,022,451 | 866,768 | 18% |
| 2024/10 | 70,009 | 54,439 | -35.7% | 28.6% | 957,904 | 782,456 | 22.4% |
| 2024/09 | 108,839 | 74,954 | 7.6% | 45.2% | 887,895 | 728,017 | 22% |
| 2024/08 | 101,133 | 81,270 | 14.2% | 24.4% | 779,056 | 653,063 | 19.3% |
| 2024/07 | 88,534 | 74,836 | -32.3% | 18.3% | 677,923 | 571,793 | 18.6% |
| 2024/06 | 130,713 | 120,162 | 17.1% | 8.8% | 589,389 | 496,957 | 18.6% |
| 2024/05 | 111,649 | 106,079 | 3.2% | 5.3% | 458,676 | 376,795 | 21.7% |
| 2024/04 | 108,216 | 83,389 | -3% | 29.8% | 347,027 | 270,716 | 28.2% |
| 2024/03 | 111,623 | 100,704 | 57.9% | 10.8% | 238,811 | 187,327 | 27.5% |
| 2024/02 | 70,701 | 68,694 | 25.2% | 2.9% | 127,188 | 86,623 | 46.8% |
| 2024/01 | 56,487 | 17,929 | -45.8% | 215.1% | 56,487 | 17,929 | 215.1% |
| 2023/12 | 104,254 | 65,488 | 23.6% | 59.2% | 971,022 | 865,506 | 12.2% |
| 2023/11 | 84,312 | 63,578 | 54.5% | 32.6% | 866,768 | 800,018 | 8.3% |
| 2023/10 | 54,551 | 60,401 | -27.1% | -9.7% | 782,456 | 736,440 | 6.2% |
| 2023/09 | 74,842 | 69,947 | -7.9% | 7% | 727,905 | 676,039 | 7.7% |
| 2023/08 | 81,270 | 73,077 | 8.5% | 11.2% | 653,063 | 606,092 | 7.7% |
| 2023/07 | 74,899 | 72,647 | -37.6% | 3.1% | 571,793 | 533,015 | 7.3% |
| 2023/06 | 120,099 | 108,108 | 13.2% | 11.1% | 496,894 | 460,368 | 7.9% |
| 2023/05 | 106,079 | 86,030 | 27.5% | 23.3% | 376,795 | 352,260 | 7% |
| 2023/04 | 83,167 | 82,346 | -17.6% | 1% | 270,716 | 266,230 | 1.7% |
| 2023/03 | 100,926 | 79,277 | 46.9% | 27.3% | 187,549 | 183,884 | 2% |
| 2023/02 | 68,694 | 47,017 | 283.1% | 46.1% | 86,623 | 104,607 | -17.2% |
| 2023/01 | 17,929 | 57,590 | -72.7% | -68.9% | 17,929 | 57,590 | -68.9% |
| 2022/12 | 65,587 | 111,455 | 3.2% | -41.2% | 865,605 | 916,866 | -5.6% |
| 2022/11 | 63,578 | 98,797 | 5% | -35.6% | 800,018 | 805,411 | -0.7% |
羅麗芬-KY四大通路串聯 看好雙11、雙12帶動下半年營收成長Anue鉅亨-2025/08/15